The investigators seek to test whether incorporating the scheduled dosing of a bisacodyl 10 mg rectal suppository every other day improves bowel-related symptoms in patients with multiple sclerosis. Patients will be randomized to receive either a placebo suppository or bisacodyl suppository dosed every other day for 4 weeks.
| Study Type : |
Interventional (Clinical Trial) |
| Estimated Enrollment : |
70 participants |
| Allocation: |
Randomized |
| Intervention Model: |
Parallel Assignment |
| Masking: |
Triple (Participant, Care Provider, Investigator) |
| Primary Purpose: |
Treatment |
| Official Title: |
Treating Anorectal Dysfunction Associated With Multiple Sclerosis |
| Study Start Date : |
June 2016 |
| Estimated Primary Completion Date : |
December 2019 |
| Estimated Study Completion Date : |
April 2020 |
Contacts
David J Levinthal, MD, PhD 412-303-0525 levinthald@upmc.edu
For enrollment please visit www.clinicaltrials.gov.
